Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition

MT newswire2026/09/29 16:43

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

12:43 PM EDT, 09/29/2026 (MT Newswires) -- H Lundbeck has been working with advisers to explore acquiring Xeris Biopharma Holdings (XERS), Bloomberg reported Tuesday, citing people familiar with the matter. There's no guarantee that Lundbeck's interest will culminate in a deal for the commercial-stage drugmaker, the report said, citing the people. The companies didn't immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 10.19, Change: +0.36, Percent Change: +3.67

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

John Williams, President of the New York Federal Reserve, stated that if the economy performs broadly in line with expectations, it may be appropriate to raise interest rates once more later this year, but the September rate hike has allowed for more observation time, and “there is no need to act in haste.” Following Williams' remarks, the market's expectation for a Federal Reserve rate hike in October fell from around 70% to about 50%.

华尔街见闻•2026/09/29 20:11

US Stock Market Movement: Meta soars on September 29 — Enterprise AI Platform and Small Business Muse

Bitget异动解读•2026/09/29 19:55

Sector Update: Consumer Stocks Mixed Late Afternoon

MT newswire•2026/09/29 19:49